Condition
Rubinstein-Taybi Syndrome
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Recruiting2
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06740162Not ApplicableRecruiting
Physical Activity and Community EmPOWERment Project
NCT05696912Not ApplicableRecruiting
Functional Tests to Resolve Unsolved Rare Diseases. Rares.
NCT04122742UnknownPrimary
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.
NCT01619644Phase 2CompletedPrimary
Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial
Showing all 4 trials